Skip to main content
Log in

High-dose atorvastatin economically IDEAL in CHD

  • Meeting report
  • Published:
PharmacoEconomics & Outcomes News

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

REFERENCE

  1. Lindgren P, Jonsson B, IDEAL trial investigators.Economic evaluation of intensive atorvastatin compared to standard simvastatin in patients with acute coronary syndrome from the IDEAL Trial. Journal of the American College of Cardiology 49 (Suppl. A): 294-295 (plus poster) abstr. 1030-181, No. 9, 6 Mar 2007

  2. Mark DB, Knight JD, Cowper PA, Davidson-Ray L, Anstrom KJ.High-dose atorvastatin - better value for money: the Treating to New Targets Trial US Economic Substudy in 5,308 stable coronary heart disease patients. Journal of the American College of Cardiology 49 (Suppl. A): 290, No. 9, 6 Mar 2007

Download references

Rights and permissions

Reprints and permissions

About this article

Cite this article

High-dose atorvastatin economically IDEAL in CHD. Pharmacoecon. Outcomes News 526, 3–4 (2007). https://doi.org/10.2165/00151234-200705260-00005

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00151234-200705260-00005

Keywords

Navigation